20:03 EDT Cathie Wood’s ARK Investment buys 460K shares of Recursion Pharmaceuticals (RXRX) today
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Biotech Alert: Searches spiking for these stocks today
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Recursion Pharmaceuticals price target lowered to $8 from $10 at Morgan Stanley
- Recursion Pharmaceuticals, Enamine release new tools in its AI/ML platform
- Recursion announces first patient dosed in Phase 1 REC-3565 study
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue